Management of Clopidogrel in Patients Undergoing PCI

Loading Dose Strategy for PCI

The American College of Cardiology recommends administering a 300-600 mg loading dose of clopidogrel as early as possible before or at the time of PCI for patients not already on clopidogrel 2, 3
A 300 mg dose given at least 6 hours before the procedure has the strongest evidence for efficacy, with a relative risk reduction in adverse events 3
A 600 mg loading dose achieves faster platelet inhibition and may be preferred when the procedure is planned within less than 6 hours, though the evidence is less established than for 300 mg 2, 3

For bare-metal stents, the American Heart Association recommends a minimum of 1 month of clopidogrel 75 mg daily, and ideally up to 12 months 3, 4
For drug-eluting stents, a minimum of 3 months for sirolimus-eluting stents and 6 months for paclitaxel-eluting stents is recommended, with at least 12 months recommended for all DES, particularly in ACS patients 1, 3, 4
For acute coronary syndromes, clopidogrel must be continued for at least 12 months regardless of stent type, as recommended by the American College of Cardiology 1, 2, 4

The American Heart Association emphasizes that patients with coronary stents should never discontinue clopidogrel, as abrupt cessation dramatically increases the risk of stent thrombosis, myocardial infarction, and death 5
The highest thrombotic risk period is within 30 days of stent placement, with an ongoing risk of 0.2-0.6% per year thereafter 5

Aspirin should be administered concurrently with clopidogrel before, during, and after PCI, as recommended by the American College of Cardiology 1, 2, 3
After PCI, aspirin 81 mg daily should be used indefinitely in preference to higher maintenance doses, as recommended by the American Heart Association 1, 4

Prasugrel (60 mg loading dose) or ticagrelor (180 mg loading dose) are reasonable alternatives to clopidogrel at the time of PCI, as recommended by the American College of Cardiology 1, 2
Prasugrel is contraindicated in patients with prior stroke or TIA, as recommended by the American Heart Association 1